跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 49,304 条关于
“DelphX Capital Markets Inc.”
全部
49,304
临床试验
15,999
药物
1,641
机构
6,291
资讯
25,373
9个月前
DelphX Capital Markets Completes C$112,000 Private Placement to Support Structured Products Development
去年
Faron Pharmaceuticals' Bexmarilimab Shows Promise in Myelodysplastic Syndrome Treatment
去年
MAIA Biotechnology's THIO Shows Promise in Phase II Lung Cancer Trial; Institutional Investment Increases
去年
Akeso's Phase 3 Trial Begins for Ivonescimab and Ligufalimab Combination in Head and Neck Cancer
去年
Apimeds Pharmaceuticals Raises $13.5M in NYSE American IPO
去年
Exelixis Downgraded to Market Perform Despite Price Target Increase to $40
12个月前
Patient Square Capital Acquires Healthcare Technology Firm Premier for $2.6 Billion
去年
IGM Biosciences Downgraded by BMO Capital Following Strategic Update
2年前
Summit Therapeutics Completes Enrollment in Phase III HARMONi Trial and Receives FDA Fast Track Designation for Ivonescimab
上个月
Cancer Research Horizons' Charity Capital Model Targets Broken Childhood Cancer Market After $1.5B Myricx Exit
第 1 页，共 2538 页
上一页
下一页
